Dementia Clinical Trials in New York, New York

8 studies are recruiting for dementia in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

   PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

   Stage

   Phase 4

   Ages

   75 and older

   Site

   VA New York Harbor Healthcare System, New York, New York

   Locations

   106 in total

   Run by

   Duke University

   See if you can join NCT04262206 on ClinicalTrials.gov

2. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

   The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Stage 1 will determine if treatment with the study drug prevents or slows the rate of amyloid beta (Aβ) pathol…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   New York University Medical Center, New York, New York

   Locations

   37 in total

   Run by

   Washington University School of Medicine

   See if you can join NCT05552157 on ClinicalTrials.gov

3. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

   The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on bioma…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   New York University Medical Center, New York, New York

   Locations

   37 in total

   Run by

   Washington University School of Medicine

   See if you can join NCT06647498 on ClinicalTrials.gov

4. Paradoxical Lucidity in Severe End-Stage Dementia

   Cognitive decline in dementia is considered irreversible, however episodes of paradoxical lucidity (PL) in severe dementia suggest other mechanisms may be in play. Beyond anecdotal reports of transient PL events occurring in patients predominantly in late-stage dementia and typically lasting anywhe…

   Stage

   Not phased

   Ages

   18 and older

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT05234866 on ClinicalTrials.gov

5. Resilient Together for Dementia (RT-D)

   This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Brain Injury Research Center at Mount Sinai, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06619327 on ClinicalTrials.gov

6. Dementia Caregivers' Link to Assistance and Resources

   The goal of this clinical trial is to learn if the Dementia Caregivers' Link to Assistance and Resources (DECLARE) program can improve support of, and engagement with, caregivers of home health patients with dementia. DECLARE includes a caregiver self-assessment that is reported in the home health …

   Stage

   Not phased

   Ages

   Any age

   Site

   VNS Health Home Care, New York, New York

   Run by

   Visiting Nurse Service of New York

   See if you can join NCT06860035 on ClinicalTrials.gov

7. Evaluating the Efficacy of the Pain Identification and Communication Toolkit

   This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techn…

   Stage

   Not phased

   Ages

   21 and older

   Site

   Weill Cornell Medicine, New York, New York

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06168604 on ClinicalTrials.gov

8. NYSCF Scientific Discovery Biobank

   The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

   Stage

   Not phased

   Ages

   0 and older

   Site

   New York Stem Cell Foundation Research Institute, New York, New York

   Run by

   New York Stem Cell Foundation Research Institute

   See if you can join NCT06203106 on ClinicalTrials.gov